Login / Signup

Pharmacodynamic Activity of [ 18 F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With BRCA1/2 -Mutated Breast Cancer Receiving Talazoparib.

Lilie L LinFranklin WongRuitao LinTimothy Anthony YapJennifer K Litton
Published in: JCO precision oncology (2024)
F]FTT in bone marrow may be an early predictor of hematologic toxicity.
Keyphrases
  • positron emission tomography
  • bone marrow
  • computed tomography
  • breast cancer risk
  • mesenchymal stem cells
  • pet ct
  • pet imaging
  • oxidative stress
  • structural basis
  • wild type
  • young adults
  • childhood cancer